基因敲除
癌基因
信使核糖核酸
癌症研究
癌症
核糖核酸
生物
下调和上调
基因
细胞周期
遗传学
作者
Jijun Yan,Juntao Liu,Zhengbin Huang,Wenwei Huang,Jianfa Lv
出处
期刊:Human Cell
[Springer Nature]
日期:2021-07-29
卷期号:34 (6): 1755-1764
被引量:15
标识
DOI:10.1007/s13577-021-00583-3
摘要
Long noncoding RNA (lncRNA) FOXC2-AS1 has been reported to act as an oncogene in multiple human cancers. However, the clinical significance, functional role and underlying mechanism of FOXC2-AS1 in gastric cancer (GC) remains largely unknown. Here, we found that FOXC2-AS1 expression was significantly elevated in GC tissues and cells, and overexpression of FOXC2-AS1 indicated advanced TNM stage and shorter overall survival in GC patients. Functionally, knockdown of FOXC2-AS1 attenuated the proliferation, migration and invasion of GC cells, whereas overexpression of FOXC2-AS1 showed the opposite effects. Further investigation revealed that FOXC2-AS1 interacted with FOXC2 mRNA and repressed its degradation. FOXC2-AS1 recruited RNA methyltransferase NSUN2 to FOXC2 mRNA, increasing its m5C level and association with YBX1. Taken together, our findings suggested that FOXC2-AS1 acted as an oncogenic lncRNA by stabilizing FOXC2 mRNA in an m5C-dependent manner, which may provide a novel therapeutic target for GC.
科研通智能强力驱动
Strongly Powered by AbleSci AI